Showing 6761-6770 of 9346 results for "".
In-Office Lunchtime Glycolic Peel Demonstration
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/in-office-lunchtime-glycolic-peel-demonstration--wimitehe/19419/In a good portion of DermTV episodes, Dr. Schultz discusses the importance of sun protection. As if you didn't need another reason, in this episode of DermTV, Dr. Schultz actually brings you into the operating room and shows you an actual skin cancer removalVerisante
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/verisante-/19449/News Reel on Vancouver, BC based Verisante discussing the company's partnership with BCCA (British Columbia Cancer Agency) to develop a new product for early skin cancer detection.Managing Acne and Rosacea in the Aesthetic Patient
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/managing-acne-and-rosacea-in-the-aesthetic-patient/23732/Sometimes patients seeking aesthetic interventions don’t even realize there is help for their inflamed skin.Aerolase’s Neo Elite 650-Microsecond 1064nm Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aerolases-neo-elite-650-microsecond-1064nm-laser/23243/A Safe, Effective Go-to Option to Treat Skin of ColorAn Update on the Use of Minocycline for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-minocycline-for-the-treatment-of-acne/23201/Advances in formulation technology have led to the development of a stable topical minocycline that recently received FDA approval. Here’s what you should know.Clascoterone: A Novel Topical Anti-androgen for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/clascoterone-a-novel-topical-anti-androgen-for-the-treatment-of-acne/23133/For the first time in almost 15 years, a new chemical entity may be coming to the market for the topical treatment of acne vulgaris.Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.Fillers and Toxins Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/fillers-and-toxins-trends/23851/A look at new and potential exciting developments in the market.Habit Reversal Therapy for Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/habit-reversal-therapy-for-atopic-dermatitis/23951/Exploring CBT’s potential role for scratching frequency, itch intensity, and topical steroid utilization in atopic dermatitis.DermWire TV Extra: How ILDS Helps Dermatology Go Global
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-how-ilds-helps-dermatology-go-global/26912/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Henry Lim, MD, president of the International League of Dermatology Societies (ILDS), to discuss international developments in research and therapeutics, how ILDS helps enhance dermatologists' interactions with the specialty worl